Evidence map›Paper›PMID 37725680›Full record

SynthesisCirculation. Heart failure2023

Common Variants on

Hongsheng Gui, W H Wilson Tang, Stephan Francke, Jia Li, Ruicong She, Peter Bazeley, Naveen L Pereira, Kirkwood Adams, Jasmine A Luzum, Thomas M Connolly and 4 more

Registry-linked trialOpen access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Circulation. Heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00475852 (Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00475852 phase3completednot on this map

Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)

TypeinterventionalSponsorScios, Inc.Ran2007 to 2011Enrolled7,141ConditionsHeart DecompensationArmsNesiritide, Placebo
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Ang-1 and VEGF: central regulators of angiogenesis.Molecular and cellular biochemistry · 2025
    Review
  4. Using Omics to Identify Novel Therapeutic Targets in Heart Failure.Circulation. Genomic and precision medicine · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 1 country.

Hongsheng GuiCenter for Individualized and Genomics Medicine Research (H.G., J.A.L., L.K.W., D.E.L.), Henry Ford Hospital, Detroit, MI.ORCID 0000-0002-0460-7446
W H Wilson TangDepartment of Cardiovascular Medicine, Cleveland Clinic, OH (W.H.W.T., P.B.).ORCID 0000-0002-8335-735X
Stephan FranckeCary, NC (S.F.).
Jia LiDepartment of Public Health Science (J.L., R.S.), Henry Ford Hospital, Detroit, MI.
Ruicong SheDepartment of Public Health Science (J.L., R.S.), Henry Ford Hospital, Detroit, MI.
Peter BazeleyDepartment of Cardiovascular Medicine, Cleveland Clinic, OH (W.H.W.T., P.B.).ORCID 0000-0002-6272-5686
Naveen L PereiraDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (N.L.P.).ORCID 0000-0003-3813-3469
Kirkwood AdamsDepartment of Medicine, University of North Carolina, Chapel Hill (K.A.).
Jasmine A LuzumCenter for Individualized and Genomics Medicine Research (H.G., J.A.L., L.K.W., D.E.L.), Henry Ford Hospital, Detroit, MI.ORCID 0000-0003-3639-717X
Thomas M ConnollyLansdale, PA, previously Janssen Research & Development LLC, Spring House, PA (T.M.C.).
Adrian F HernandezDuke Clinical Research Institute, Durham, NC (A.F.H.).ORCID 0000-0003-3387-9616
Candace D McNaughtonDepartment of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN (C.D.M.).ORCID 0000-0003-0095-9134
L Keoki WilliamsCenter for Individualized and Genomics Medicine Research (H.G., J.A.L., L.K.W., D.E.L.), Henry Ford Hospital, Detroit, MI.ORCID 0000-0002-7592-5791
David E LanfearCenter for Individualized and Genomics Medicine Research (H.G., J.A.L., L.K.W., D.E.L.), Henry Ford Hospital, Detroit, MI.ORCID 0000-0001-6471-1483
Henry Ford Hospital · USCleveland Clinic · USClinical Research Institute · USMayo Clinic · USPMG Research · USSpringhouse · USUniversity of Michigan · USUniversity of North Carolina at Chapel Hill · USVanderbilt University Medical Center · US

Funding

ACHIEVE P3 - CHDP50MD017351 · NIMHD · WAYNE STATE UNIVERSITY · PI DAILEY, RHONDA K · 2021 to 2025
$21.1M
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMAR01AI079139 · NIAID · HENRY FORD HEALTH SYSTEM · PI WILLIAMS, KEOKI · 2009 to 2013
$3.9M
Impact of Race and Genetic Factors on Beta-blocker Effectiveness in Heart FailureR01HL103871 · NHLBI · HENRY FORD HEALTH SYSTEM · PI LANFEAR, DAVID E · 2011 to 2015
$3.5M
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populationsR01DK113003 · NIDDK · HENRY FORD HEALTH SYSTEM · PI WILLIAMS, KEOKI · 2017 to 2021
$3.2M
Plasma Metabolomics and Myocardial Energetics in Heart FailureR01HL132154 · NHLBI · HENRY FORD HEALTH SYSTEM · PI LANFEAR, DAVID E, SABBAH, HANI N · 2017 to 2020
$3.1M
Poly-omic Study of Asthma Exacerbations in Diverse PopulationsR01HL141845 · NHLBI · HENRY FORD HEALTH SYSTEM · PI WILLIAMS, KEOKI · 2019 to 2022
$3.0M
Minimally Invasive Ventricular Polymeric Injection for Treatment of Heart FailureR01HL118627 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI GUCCIONE, JULIUS MATTEO, KASSAB, GHASSAN S · 2013 to 2016
$3.0M
VALIDATION OF ADHERENCE DATA--USE IN CLINICAL PRACTICER01DK064695 · NIDDK · HENRY FORD HEALTH SYSTEM · PI WILLIAMS, KEOKI · 2003 to 2010
$2.7M
Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone PharmacotherapyK08HL146990 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUZUM, JASMINE A · 2019 to 2023
$772k
NHLBI NIH HHS K08 HL146990NHLBI NIH HHS L30 HL110279NHLBI NIH HHS R01 HL103871NHLBI NIH HHS R01 HL118627NHLBI NIH HHS R01 HL132154NHLBI NIH HHS R01 HL141845NIAID NIH HHS R01 AI079139NIDDK NIH HHS R01 DK064695NIDDK NIH HHS R01 DK113003NIMHD NIH HHS P50 MD017351
6 · The paper itself

Abstract

backgroundHeart failure remains a global health burden, and patients hospitalized are particularly at risk, but genetic associates for subsequent death or rehospitalization are still lacking.

methodsThe genetic substudy of the ASCEND-HF trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) was used to perform genome-wide association study and transethnic meta-analysis. The overall trial included the patients of self-reported European ancestry (n=2173) and African ancestry (n=507). The end point was death or heart failure rehospitalization within 180 days. Cox models adjusted for 11 a priori predictors of rehospitalization and 5 genetic principal components were used to test the association between single-nucleotide polymorphisms and outcome. Summary statistics from the 2 populations were combined via meta-analysis with the significance threshold considered

resultsCommon variants (rs2342882 and rs35850039 in complete linkage disequilibrium) located in

conclusionsIn this multiethnic genome-wide association study of ASCEND-HF, single-nucleotide polymorphisms in REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT00475852.

Indexed as

Heart FailureGenome-Wide Association StudyGuanine Nucleotide Exchange FactorsHumansNatriuretic Peptide, BrainPatient ReadmissionVascular Endothelial Growth Factor AFGD5 protein, humanGuanine Nucleotide Exchange FactorsNatriuretic Peptide, BrainVascular Endothelial Growth Factor Aheart failurehospitalizationhumansmeta-analysissurvival

Identifiers

PMID37725680
PMCPMC10597552
OpenAlexW4385317882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.